0001104659-15-056484.txt : 20150805 0001104659-15-056484.hdr.sgml : 20150805 20150805160248 ACCESSION NUMBER: 0001104659-15-056484 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150731 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc CENTRAL INDEX KEY: 0001444307 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980573252 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54318 FILM NUMBER: 151028947 BUSINESS ADDRESS: STREET 1: 9810 SUMMERS RIDGE RD SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 210-7333 MAIL ADDRESS: STREET 1: 9810 SUMMERS RIDGE RD SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: NetVentory Solutions, Inc. DATE OF NAME CHANGE: 20080902 8-K 1 a15-16971_18k.htm 8-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 31, 2015

 

OncoSec Medical Incorporated

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54318

 

98-0573252

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

9810 Summers Ridge Road, Suite 110
San Diego, CA

 

92121

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (855) 662-6732

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07                                           Submission of Matters to a Vote of Security Holders.

 

On July 31, 2015, OncoSec Medical Incorporated (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) in the Lighthouse room located at 10996 Torreyana Road, San Diego, California 92121.

 

The final voting results on the matters presented at the Annual Meeting were as follows:

 

Proposal 1—To elect four directors to the Company’s Board of Directors to serve for a term of one year or until successors are duly elected and qualified.

 

Directors

 

For

 

Withheld

 

Broker Non-Votes

Dr. Avtar Dhillon

 

2,120,040

 

123,740

 

7,424,968

Dr. Anthony Maida

 

2,147,273

 

96,507

 

7,424,968

Dr. James DeMesa

 

2,141,371

 

102,409

 

7,424,968

Punit Dhillon

 

2,088,216

 

155,564

 

7,424,968

 

Proposal 2—To ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2015.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

9,030,647

 

558,393

 

79,708

 

—

 

Proposal 3—To amend the 2011 Stock Incentive Plan to increase the shares reserved for issuance thereunder and increase the annual per person limit on stock options, stock appreciation rights, restricted stock and restricted stock units that are intended to qualify for exclusion from the federal tax deduction limitation under Section 162(m) of the Internal Revenue Code.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

1,749,603

 

430,644

 

63,533

 

7,424,968

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 5, 2015

 

OncoSec Medical Incorporated

 

 

 

 

By:

/s/ Punit Dhillon

 

 

Name:

Punit Dhillon

 

 

Title:

President and Chief Executive Officer

 

1